Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Presentation to Annual General Meeting

23 November 2021 by Audrey Thomson

Presentation to Annual General Meeting

Categories 2021, ASX Announcements
Post navigation
Commencement of Two Pivotal BIT225 Clinical Trials
Results of Annual General Meeting
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 2 May 2022        Legal Notices and Privacy